Compound Detail
CHEMBL3309539
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3309539 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SSIKSTLTDVIQSK-UHFFFAOYSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
444.8
MW (Da)
6.30
ALogP
2
HBA
1
HBD
49.2
PSA (Ų)
0.39
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 4.59
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HepG2 CHEMBL395 | IC50 | 4.59 | 4.59 | 25520.0 | 1 |
| Leishmania donovani CHEMBL367 | IC50 | 4.43 | 4.415 | 37100.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 25520.0 | nM | 4.59 | Cytotoxicity against human HepG2 cells after 48 hrs by neutral red assay | 24980054 |
| Leishmania donovani | IC50 | = | 37100.0 | nM | 4.43 | Antimicrobial activity against axenic amastigote stage of Leishmania donovani af... | 24980054 |
| Leishmania donovani | IC50 | = | 39600.0 | nM | 4.4 | Antimicrobial activity against promastigote stage of Leishmania donovani after 7... | 24980054 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24980054 | 10.1016/j.bmcl.2014.06.030 | Leishmania donovani | 6 |
| 24980054 | 10.1016/j.bmcl.2014.06.030 | Trypanosoma brucei | 2 |
| 24980054 | 10.1016/j.bmcl.2014.06.030 | THP-1 | 1 |
| 24980054 | 10.1016/j.bmcl.2014.06.030 | HepG2 | 1 |
| 26560048 | 10.1016/j.ejmech.2015.10.049 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine